Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$262.75 - $319.31 $348,932 - $424,043
1,328 New
1,328 $414,000
Q2 2022

Aug 10, 2022

BUY
$230.71 - $256.74 $9,689 - $10,783
42 Added 17.87%
277 $68,000
Q1 2022

Apr 29, 2022

SELL
$219.27 - $242.57 $85,515 - $94,602
-390 Reduced 62.4%
235 $57,000
Q4 2021

Feb 08, 2022

BUY
$198.88 - $227.6 $36,395 - $41,650
183 Added 41.4%
625 $141,000
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $93,823 - $109,925
442 New
442 $94,000
Q2 2021

Aug 06, 2021

SELL
$233.58 - $259.14 $20,087 - $22,286
-86 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $1.62 Million - $1.89 Million
-7,311 Reduced 98.84%
86 $22,000
Q4 2020

Feb 09, 2021

BUY
$216.38 - $257.67 $1.41 Million - $1.68 Million
6,522 Added 745.37%
7,397 $1.7 Million
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $205,318 - $228,331
875 New
875 $223,000
Q2 2020

Aug 07, 2020

SELL
$197.81 - $242.74 $195,831 - $240,312
-990 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$182.24 - $241.7 $180,417 - $239,283
990 New
990 $201,000
Q4 2019

Feb 13, 2020

SELL
$189.21 - $243.2 $978,215 - $1.26 Million
-5,170 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $44,223 - $52,989
-254 Reduced 4.68%
5,170 $1 Million
Q2 2019

Aug 13, 2019

SELL
$166.7 - $195.41 $1.97 Million - $2.31 Million
-11,844 Reduced 68.59%
5,424 $1.01 Million
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $135,652 - $152,910
-750 Reduced 4.16%
17,268 $0
Q4 2018

Feb 15, 2019

BUY
$178.4 - $208.25 $3.21 Million - $3.75 Million
18,018 New
18,018 $3.51 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $142B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gladius Capital Management LP Portfolio

Follow Gladius Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Gladius Capital Management LP with notifications on news.